676 Results

People

  1. Robson
    Robson
  2. Offit
    Offit
  3. Stadler
    Stadler
  4. Joseph
    Joseph
  5. Mandelker
    Mandelker
  6. Berger
    Berger
  7. Solit
    Solit
  8. Hudis
    Hudis
  9. Kauff
    Kauff
  10. Kemel
    Kemel

Groups

  1. Breast Medicine Service (676)
  2. Department of Medicine (676)
  3. Population Sciences Research Program (676)
  4. Solid Tumor Oncology Division (676)
  5. Survivorship Research (676)
  6. GSK Faculty (376)
  7. Clinical Genetics Service (297)
  8. Surgery (188)
  9. Department of Pathology and Laboratory Medicine (187)
  10. Epidemiology and Biostatistics (185)
  1. "Mark Robson"
Formats
  1. Journal Article (382)
  2. Meeting Abstract (259)
  3. Review (10)
  4. Book Section (7)
  5. Editorial (6)
  6. Guidelines (6)
  7. Miscellaneous (4)
  8. Correspondence (1)
  9. Research Letter (1)
Groups
  1. Breast Medicine Service (676)
  2. Department of Medicine (676)
  3. Population Sciences Research Program (676)
  4. Solid Tumor Oncology Division (676)
  5. Survivorship Research (676)
  6. GSK Faculty (376)

More Groups

People
  1. Mark Robson (676)
  2. Kenneth Offit (280)
  3. Zsofia Stadler (116)
  4. Larry Norton (89)
  5. Vijai Joseph (79)
  6. Diana Mandelker (74)

More People

Years
  1. 2025 (2)
  2. 2024 (32)
  3. 2023 (41)
  4. 2022 (34)
  5. 2021 (46)
  6. 2020 (65)

More Years

Publications
  1. Journal of Clinical Oncology (163)
  2. Cancer Research (50)
  3. Breast Cancer Research and Treatment (33)
  4. JNCI: Journal of the National Cancer Institute (20)
  5. Annals of Oncology (18)
  6. Clinical Cancer Research (17)

More Publications

Publishers
  1. American Society of Clinical Oncology (185)
  2. American Association for Cancer Research (82)
  3. Springer (66)
  4. Nature Publishing Group (60)
  5. Elsevier Inc. (50)
  6. Oxford University Press (42)

More Publishers

Results (676)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Surgical decision making and clinical outcomes in breast cancer (BC) patients (pts) with germline alterations in moderate risk BC susceptibility genes (CHEK2, PALB2 and ATM)
    Meeting Abstract

    dos Anjos, C. H.; Amoros, K.; Pilewskie, M.; Braunstein, L.; Robson, M.
    Cancer Research (2020)

    Fulltext@MSK | Save
  • Genomic profiling of primary and metastatic breast cancer in men
    Meeting Abstract

    Drago, J. Z.; Serna-Tamayo, C.; Dos Anjos, C. H.; Brown, D. N.; Modi, S.; Jhaveri, K.; Solit, D. B.; Traina, T. A.; Chandarlapaty, S.; Reis-Filho, J. S.; more...
    Cancer Research (2020)

    Fulltext@MSK | Save
  • Cascading after peridiagnostic cancer genetic testing: An alternative to population-based screening
    Journal Article

    Offit, K.; Tkachuk, K. A.; Stadler, Z. K.; Walsh, M. F.; Diaz-Zabala, H.; Levin, J. D.; Steinsnyder, Z.; Ravichandran, V.; Sharaf, R. N.; Frey, M. K.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Illustrating cancer risk: Patient risk communication preferences and interest regarding a novel BRCA1/2 genetic risk modifier test
    Journal Article

    Hamilton, J. G.; Genoff Garzon, M.; Shah, I. H.; Cadet, K.; Shuk, E.; Westerman, J. S.; Hay, J. L.; Offit, K.; Robson, M. E.
    Public Health Genomics (2020)

    Fulltext@MSK | Save
  • Transcriptome-wide association study of breast cancer risk by estrogen-receptor status
    Journal Article

    Feng, H.; Gusev, A.; Pasaniuc, B.; Wu, L.; Long, J.; Abu-full, Z.; Aittomäki, K.; Andrulis, I. L.; Anton-Culver, H.; Antoniou, A. C.; more...
    Genetic Epidemiology (2020)

    Fulltext@MSK | Save
  • Olaparib monotherapy for Asian patients with a germline BRCA mutation and HER2-negative metastatic breast cancer: OlympiAD randomized trial subgroup analysis
    Journal Article

    Im, S. A.; Xu, B.; Li, W.; Robson, M.; Ouyang, Q.; Yeh, D. C.; Iwata, H.; Park, Y. H.; Sohn, J. H.; Tseng, L. M.; more...
    Scientific Reports (2020)

    Fulltext@MSK | Save
  • Development and validation of a clinical polygenic risk score to predict breast cancer risk
    Journal Article

    Hughes, E.; Tshiaba, P.; Gallagher, S.; Wagner, S.; Judkins, T.; Roa, B.; Rosenthal, E.; Domchek, S.; Garber, J.; Lancaster, J.; more...
    JCO Precision Oncology (2020)

    Fulltext@MSK | Save
  • Protein-altering germline mutations implicate novel genes related to lung cancer development
    Journal Article

    Ji, X.; Mukherjee, S.; Landi, M. T.; Bosse, Y.; Joubert, P.; Zhu, D.; Gorlov, I.; Xiao, X.; Han, Y.; Gorlova, O.; more...
    Nature Communications (2020)

    Fulltext@MSK | Save
  • Impact of the 2018 American Society of Clinical Oncology/College of American Pathologists HER2 guideline updates on HER2 assessment in breast cancer with equivocal HER2 immunohistochemistry results with focus on cases with HER2/CEP17 ratio <2.0 and average HER2 copy number ≥4.0 and <6.0
    Journal Article

    Hoda, R. S.; Brogi, E.; Xu, J.; Ventura, K.; Ross, D. S.; Dang, C.; Robson, M.; Norton, L.; Morrow, M.; Wen, H. Y.
    Archives of Pathology & Laboratory Medicine (2020)

    Fulltext@MSK | Save
  • Effectiveness of the Genomics ADvISER decision aid for the selection of secondary findings from genomic sequencing: A randomized clinical trial
    Journal Article

    Bombard, Y.; Clausen, M.; Shickh, S.; Mighton, C.; Casalino, S.; Kim, T. H. M.; Muir, S. M.; Carlsson, L.; Baxter, N.; Scheer, A.; more...
    Genetics in Medicine (2020)

    Fulltext@MSK | Save